Alpha Tau Medical
(NASDAQ:DRTS)
$2.60
0.10[4.00%]
At close: Apr 18
$2.60
0[0.00%]
PreMarket: 6:38PM EDT
Consensus Rating1
Buy
Highest Price Target1
$23.00
Lowest Price Target1
$7.00
Consensus Price Target1
$13.60

Alpha Tau Medical Stock (NASDAQ:DRTS), Analyst Ratings, Price Targets, Predictions

Alpha Tau Medical Ltd has a consensus price target of $13.6, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Piper Sandler, and Citigroup on March 12, 2024, March 8, 2024, and December 15, 2023. With an average price target of $8 between HC Wainwright & Co., Piper Sandler, and Citigroup, there's an implied 220.00% upside for Alpha Tau Medical Ltd from these 3 analyst ratings.

Analyst Trend
2
Nov 23
1
Dec 23
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Piper Sandler
Citigroup
Cantor Fitzgerald
Citigroup

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Alpha Tau Medical

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/12/2024DRTSBuy Now
Alpha Tau Medical
$2.50260%HC Wainwright & Co.
Yi Chen
→ $9ReiteratesBuy → BuyGet Alert
03/08/2024DRTSBuy Now
Alpha Tau Medical
$2.50180%Piper Sandler
Jason Bednar
$8 → $7ReiteratesOverweight → OverweightGet Alert
12/15/2023DRTSBuy Now
Alpha Tau Medical
$2.50220%Citigroup
Ashiq Mubarack
→ $8Initiates → BuyGet Alert
11/20/2023DRTSBuy Now
Alpha Tau Medical
$2.50260%HC Wainwright & Co.
Yi Chen
→ $9ReiteratesBuy → BuyGet Alert
11/17/2023DRTSBuy Now
Alpha Tau Medical
$2.50220%Piper Sandler
Jason Bednar
$12 → $8MaintainsOverweightGet Alert
09/20/2023DRTSBuy Now
Alpha Tau Medical
$2.50260%HC Wainwright & Co.
Yi Chen
→ $9ReiteratesBuy → BuyGet Alert
08/29/2023DRTSBuy Now
Alpha Tau Medical
$2.50260%HC Wainwright & Co.
Yi Chen
→ $9ReiteratesBuy → BuyGet Alert
08/29/2023DRTSBuy Now
Alpha Tau Medical
$2.50820%Cantor Fitzgerald
Kristen Kluska
→ $23ReiteratesOverweight → OverweightGet Alert
08/18/2023DRTSBuy Now
Alpha Tau Medical
$2.50260%HC Wainwright & Co.
Yi Chen
→ $9ReiteratesBuy → BuyGet Alert
05/24/2023DRTSBuy Now
Alpha Tau Medical
$2.50260%HC Wainwright & Co.
Yi Chen
→ $9ReiteratesBuy → BuyGet Alert
05/18/2023DRTSBuy Now
Alpha Tau Medical
$2.50260%HC Wainwright & Co.
Yi Chen
→ $9ReiteratesBuy → BuyGet Alert
05/15/2023DRTSBuy Now
Alpha Tau Medical
$2.50260%HC Wainwright & Co.
Yi Chen
→ $9ReiteratesBuy → BuyGet Alert
04/24/2023DRTSBuy Now
Alpha Tau Medical
$2.50260%HC Wainwright & Co.
Yi Chen
→ $9Initiates → BuyGet Alert
11/23/2022DRTSBuy Now
Alpha Tau Medical
$2.50380%Piper Sandler
Jason Bednar
$19 → $12MaintainsOverweightGet Alert
04/14/2022DRTSBuy Now
Alpha Tau Medical
$2.50700%Cantor Fitzgerald
Kristen Kluska
→ $20Initiates → OverweightGet Alert
04/08/2022DRTSBuy Now
Alpha Tau Medical
$2.50660%Piper Sandler
Jason Bednar
→ $19Initiates → OverweightGet Alert
04/04/2022DRTSBuy Now
Alpha Tau Medical
$2.50740%Citigroup
Neena Bitritto-Garg
→ $21Initiates → BuyGet Alert

FAQ

Q

What is the target price for Alpha Tau Medical (DRTS)?

A

The latest price target for Alpha Tau Medical (NASDAQ: DRTS) was reported by HC Wainwright & Co. on March 12, 2024. The analyst firm set a price target for $9.00 expecting DRTS to rise to within 12 months (a possible 246.15% upside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Alpha Tau Medical (DRTS)?

A

The latest analyst rating for Alpha Tau Medical (NASDAQ: DRTS) was provided by HC Wainwright & Co., and Alpha Tau Medical reiterated their buy rating.

Q

When was the last upgrade for Alpha Tau Medical (DRTS)?

A

There is no last upgrade for Alpha Tau Medical.

Q

When was the last downgrade for Alpha Tau Medical (DRTS)?

A

There is no last downgrade for Alpha Tau Medical.

Q

When is the next analyst rating going to be posted or updated for Alpha Tau Medical (DRTS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on March 12, 2024 so you should expect the next rating to be made available sometime around March 12, 2025.

Q

Is the Analyst Rating Alpha Tau Medical (DRTS) correct?

A

While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a reiterated with a price target of $0.00 to $9.00. The current price Alpha Tau Medical (DRTS) is trading at is $2.60, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch